Demonstrates a new prognostic model for predicting survival in ovarian cancer patients, suggesting significant clinical applications.
Mitochondrial dysfunction drives ovarian cancer (OC) progression. This study constructed a robust prognostic model (MITO-OC) based on mitochondria-related genes using ten machine-learning algorithms on TCGA, ICGC, and GEO data. We identified 241 differentially expressed genes and built the optimal MITO-OC model using StepCox[forward] and RSF algorithms (C-index=0.73). The model accurately predicts patient overall survival and strongly correlates with tumor immune infiltration. Furthermore, single-cell and pan-cancer analyses highlighted CHCHD2 as a critical component in OC and other tumors. MITO-OC provides a highly effective, personalized prognostic tool and reveals underlying metabolic mechanisms for OC clinical management.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: